Artificial Intelligence (AI) and the development of new Covid-19 treatments

by | Dec 19, 2020 | Blog, Covid 19

The use of innovative technologies like Artificial Intelligence (AI) has been invaluable in a lot of the research being carried out during the Coronavirus pandemic. Algorithms which examine the relationships between disease and existing drugs can crunch data quickly. Drug re-purposing is a huge opportunity aided by AI; collaborative work is also aiding research. We do not need to want for old fashioned serendipity.

Testimonials

Having just completed the very informative API and Clinical Trail course (thank you Shankar) I was reminded of the traps we can fall into whereby we try to keep ourselves in our little boxes. At the MHRA symposium, I have heard several times comments such as:- “no, I’m not doing the GMP day as it’s not relevant to me” or “GDP? Oh, that doesn’t apply to us as we are manufacturers”. I am sure these comments were made well out of the earshot of MHRA personnel and on the face of it see… Read more
API and Clinical Trails Training